✦ LIBER ✦
40 kDa peginterferon alfa-2A (PEGASYS®) in post-liver transplant recipients with established recurrent hepatitis C: preliminary results of a randomized multicenter trial: Peter Ferenci, Markus Peck-Radosavljevic, University of Vienna, Wien Austria; Wolfgang Vogel, Ivo Graziadei, Medical University, Innsbruck, Innsbruck Austria; Caroline Riely, University of Tennessee, Memphis, TN; Michael D Voigt, University of Iowa, Iowa City, IA; Ian M Marks, Richard Cambron, Lucy Wynohradnyk, S Chris Pappas, Roche Laboratories Inc, Nutley, NJ
- Book ID
- 118689315
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 189 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.